Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report
2010
Background
Rituximab is a monoclonal antibody inducing depletion of B lymphocytes and presently approved for the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. Here is the first report of the use of this drug in a case of Cogan's syndrome (CS).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
12
References
39
Citations
NaN
KQI